Authors: Karen G Farrar University of Southern California , Los Angeles, CA, Duy Do Truveta, Inc , Bellevue, WA, Nina B Masters Truveta, Inc , Bellevue, WA, Brianna M Cartwright Truveta, Inc , Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in July 2025, switching from anti-obesity tirzepatide surged from 0.6% to 9.7%, representing more than a 16-fold rise
Conclusion This review identified and evaluated 6 definitions and 6 methods for assessing saturation of qualitative data
GLP-1 injectable medications were already growing significantly in employee interest and use
DrTelx.com, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s
In short: powerful class, very useful when appropriately prescribed, but best treated as long-term metabolic therapy, not a shortcut detached from clinical monitoring, nutrition, resistance training and follow-up